NamaziMR. Hypothesis: The potential utility of topical eflornithine against cutaneous leishmaniasis. Indian J Dermatol Venereol Leprol, 2008; 74:158–159.
BrooksJR. Treatment of hirsutism with 5 alpha-reductase inhibitors. Clin Endocrinol Metab, 1986; 15:391–405.
4.
LakrycEM, MottaEL, SoaresJMJret al.The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism. Gynecol Endocrinol, 2003; 17:57–63.
5.
PaparodisR, DunaifA. The hirsute woman: Challenges in the evaluation and management. Endocr Pract, 2011August19:1–41e-pub ahead of print.
6.
CostelloMF, ShresthaB, EdenJet al.Metformin versus oral contraceptive pill in polycystic ovary syndrome: A Cochrane review. Hum Reprod, 2007; 22:1200–1209.
7.
TanJK, DegreefH. Oral contraceptives in the treatment of acne. Skin Ther Lett, 2001; 6:13.
8.
QiLW, WangCZ, YuanCS. Ginsenosides from American ginseng: Chemical and pharmacological diversity. Phytochemistry, 2011; 72:689–699.
9.
LeeJY, ShinJW, ChunKSet al.Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin. Carcinogenesis, 2005; 26:359–367.
10.
LiuWK, XuSX, CheCT. Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci, 2000; 67:1297–1306.
11.
ShangW, YangY, JiangBet al.Ginsenoside Rb1 promotes adipogenesis in 3T3-L1 cells by enhancing PPARgamma2 and C/EBPalpha gene expression. Life Sci, 2007; 80:618–625.
12.
MurphyLL, LeeTJ. Ginseng, sex behavior, and nitric oxide. Ann N Y Acad Sci, 2002; 962:372–377.
13.
ChoJ, ParkW, LeeSet al.Ginsenoside-Rb1 from Panax ginseng C.A. Meyer activates estrogen receptor-alpha and -beta, independent of ligand binding. J Clin Endocrinol Metab, 2004; 89:3510–3515.
